Sodium valproate, a histone deacetylase inhibitor, is associated with reduced stroke risk after previous ischemic stroke or transient ischemic attack.Brookes, R.L., Crichton, S., Wolfe, C.D., Yi, Q., Li, L., Hankey, G.J., Rothwell, P.M. and Markus, H.S., 2018. Stroke, 49(1), pp.54-61.